United Kingdom· GB-APID-44147011000001106
Eribulin 880micrograms/2ml solution for injection vials
A eribulin product containing eribulin, registered in United Kingdom by Genus Pharmaceuticals Ltd. The same ATC class is registered in 18 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Eribulin is registered in 18 of 19 countries.
Countries holding a registration under ATC L01XX41 (eribulin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Eribulin · ATC L01XX41
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Eribulin
- Manufacturer
- Genus Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XX41
- ATC class
- Eribulin
- Defined daily dose
- 0.21 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5011309109115
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for eribulin.
Graded by severity as the source publishes them — 93 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eribulin · interactions on record
428 records
- 93 severe
- 331 moderate
- 4 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eribulin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaERHOPANAAGmed s.r.o., Ostrava
- United Stateseribulin mesylateApotex Corp.
- SpainERIBULINA ADVANZ PHARMA 0,44 MG/ML SOLUCIÓN INYECTABLE EFGAdvanz Pharma Limited
- SwedenEribulin Accord 0,44 mg/ml Injektionsvätska, lösningAccord Healthcare B.V.
- FinlandEribulin AccordAccord Healthcare B.V.
- BelgiumEribulin Advanz Pharma 0.44 mg/mlAdvanz Pharma
- IcelandEribulin Advanz PharmaADVANZ PHARMA Limited
- IrelandEribulin Accord 0.44 mg/ml solution for injectionAccord Healthcare Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Eribulin Accord, Eribulin Advanz Pharma
- Belgium · Eribulin Advanz Pharma, Eribulin Eg
- Bulgaria · Eribulin Ever Pharma, Sclarint
- Czechia · Erhopana, Eribulin Accord
- Germany · Eribulin Aqvida, Eribulin Beta
- Denmark · Eribulin Accord, Eribulin Ever Pharma
- Estonia · Eribulin, Eribulin Accord
- Spain · Eribulina, Eribulina Advanz Pharma
- Finland · Eribulin, Eribulin Accord
- France · Eribuline Accord, Eribuline Advanz Pharma
- Greece · Eribulin Ever Pharma
- Croatia · Eribulin, Eribulin Accord
- Hungary · Eribulin Advz, Eribulin Ever Pharma
- Ireland · Eribulin Advanz Pharma, Eribulin Ever Pharma
- Iceland · Advz, Eribulin Advanz Pharma
- Italy · Eribulina Advanz Pharma, Eribulina Eg
- Liechtenstein · Eribulin Baxter, Halaven
- Lithuania · Eribulin, Eribulin Accord
- Luxembourg · Eribulin Eg
- Latvia · Eribulin, Eribulin Advz
- Malta · Eribulin Tillomed
- Netherlands · Eribulin Ever Pharma, Eribuline Hikma
- Norway · Eribulin Accord, Eribulin Advanz Pharma
- Poland · Eribulin Ever Pharma
- Portugal · Eribulina Advanz Pharma, Eribulina Cttq
- Romania · Erhopana, Eribulin Ever Pharma
- Sweden · Eribulin, Eribulin Accord
- Slovenia · Eribulin Ever Pharma
- Slovakia · Eribulin Advz, Eribulin Agmed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/99fec947-842e-4682-97c2-ea5ad53bd778 GET /v1/drugs/99fec947-842e-4682-97c2-ea5ad53bd778?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "44147011000001106",
"desc": "Eribulin 880micrograms/2ml solution for injection vials (Genus Pharmaceuticals Ltd)",
"form": "Solution for injection",
"vpid": "18781111000001100",
"source": "dmd",
"vtm_id": "775817009",
"strength": "440 microgram",
"substance": "Eribulin",
"ingredient": "Eribulin mesilate",
"supplier_code": "2945601000001100"
}See everything about eribulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.